NetworkNewsBreaks

WednesdayJul 15, 2020 9:39 am

NetworkNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) to Present in Alliance Global Partners’ Virtual Tech Talk

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, on Tuesday announced that its management team will give a company update and share their current views on the industry in a virtual Tech Talk hosted by Brian Kinstlinger, Head of Technology Research at Alliance Global Partners. iClick’s presentation is scheduled to begin at 10:00 a.m. Eastern Time on July 16, 2020. Interested parties may register for the Tech Talk by visiting the following link: http://nnw.fm/7UmxM. To view the full press release, visit http://nnw.fm/Hf2bu About iClick Interactive Asia Group Limited iClick Interactive Asia…

Continue Reading

WednesdayJul 15, 2020 9:02 am

NetworkNewsBreaks – The JBoy Show Features Man Behind Uber-Successful Auburn Baseball Program

The JBoy Show podcast, hosted by Jake Crain and providing an in-depth look at Southeastern Conference (“SEC”) sports with a focus on the SEC West, recently released an episode featuring Auburn head baseball Coach Butch Thompson. During the interview, Thompson, who led the Auburn team to the college world series, opened up about identity and more. “I would say I’m learning more about these players. I’m learning more about them as people,” the coach said, discussing the challenges and upsides of recruiting during COVID-19, which includes relying on phone calls and video replays as opposed to travel and watching live…

Continue Reading

TuesdayJul 14, 2020 1:38 pm

NetworkNewsBreaks – Pure Extracts Corp. Moves to Further Expand in the Functional Mushrooms Market

Pure Extracts, a private, plant-based extraction company, is focused on becoming a dominant extraction company in the functional mushrooms market, as well as a leader in the rapid development and commercialization of products in the emerging sector. A recent article discussing this reads, “Further establishing its power in the market, Pure Extracts has signed nondisclosure agreements to explore joint-development endeavors for product launches slated for potential Q4 delivery. The company also inked an advisory agreement with Dr. Alexander MacGregor, founder of Transpharm Canada Inc., the parent company of Toronto Institute of Pharmaceutical Technology, whose facility is a fully compliant Health…

Continue Reading

TuesdayJul 14, 2020 12:19 pm

NetworkNewsBreaks – Neurocrine Biosciences, Inc. (NASDAQ: NBIX) Featured in Mizuho Securities Research Report

Neurocrine Biosciences (NASDAQ: NBIX) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Neurocrine has announced a list price of $590 for a 30-count bottle of their new product Ongentys for the adjunctive treatment of Parkinson's disease. This is in-line with Neurocrine's previous commentary and should not come as a surprise. The company also continues to expect to launch the product later this year after working through supply issues they have been dealing with for the product. We continue to see Ongentys as a modest commercial opportunity with 2028 sales of ~$250M,…

Continue Reading

TuesdayJul 14, 2020 12:15 pm

NetworkNewsBreaks – Karuna Therapeutics, Inc. (NASDAQ: KRTX) Featured in Mizuho Securities Research Report

Karuna Therapeutics (NASDAQ: KRTX) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We had the opportunity to host investor meetings with the management team of Karuna Therapeutics, including CEO Steve Paul and CFO Troy Ignezi. As expected, investors were mainly focused on the progress Karuna is making in moving lead asset KarXT into Phase 3 development for the treatment of acute psychosis in patients with schizophrenia. However, investors are also clearly looking into KarXT's potential to move into additional indications, most notably dementia-related psychosis. We present our key takeaways from the…

Continue Reading

TuesdayJul 14, 2020 11:45 am

NetworkNewsBreaks – Why DarioHealth Corp. (NASDAQ: DRIO) Is ‘One to Watch’

DarioHealth (NASDAQ: DRIO) is a pioneer in the global digital therapeutics market focused on delivering evidence-based interventions to people with chronic conditions. A recent article discussing DarioHealth reads, “Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.” To view the full article, visit http://nnw.fm/WHc7s About DarioHealth Corp. DarioHealth is a leading, global, digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality…

Continue Reading

TuesdayJul 14, 2020 11:33 am

NetworkNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Announces E-Commerce Launch of A88CBD(TM) Topical and Ingestible Product Lines

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline water, flavored-infused waters and CBD infused products, today announced that A88CBD(TM)’s complete product offerings will be available to purchase at Direct CBD Online—a high-quality CBD retailer—starting this week. “We are thrilled to announce that A88CBD(TM) is expanding its digital footprint and national presence by launching its complete topical and ingestible product lines on Direct CBD Online’s e-commerce site,” Richard Wright, president and CEO of The Alkaline Water Company, stated in the news release. “Direct CBD Online is known for carrying the highest quality natural hemp brands,…

Continue Reading

TuesdayJul 14, 2020 11:24 am

NetworkNewsBreaks – Why Cybin Corp. Is ‘One to Watch’

Cybin Corp. is Canada's premier mushroom life-sciences company focused on advancing psychedelic and nutraceutical-based products derived from fungi. A recent article discussing the company reads, “In particular, Cybin aims to further build upon and expand its intellectual property (‘IP’) portfolio, which is structured around unique psilocybin delivery mechanisms that target a number of different therapeutic indications. In addition, the company has dedicated itself toward furthering its research and IP within the fields of synthetic compounds, extraction methods, the isolation of chemical compounds, new drug formulations and protocol regimes.” To view the full article, visit http://nnw.fm/Qye0A About Cybin Cybin is a…

Continue Reading

TuesdayJul 14, 2020 11:03 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces New Board Appointments

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the appointment of three new members to the company’s board of directors, effective immediately. According to the update, joining the board as independent directors are: Dr. Nancy Chung-Welch, Ph.D., Charles L. Nuzum, CPA and Greg St. Clair. “These appointments signify our absolute commitment to aligning our Board’s expertise with the company’s strategic vision of developing and commercializing an offering that will enable us to support the improvement in healthcare outcomes for oncology patients and increase value to our shareholders,”…

Continue Reading

TuesdayJul 14, 2020 10:56 am

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Poised for Opportunity in the Business of Big Data

SRAX (NASDAQ: SRAX) is positioned for opportunity in the business of big data, leveraging technology that unlocks information to reveal brands’ core consumers and their characteristics across several marketing channels. SRAX’s BIGtoken platform integrates all aspects of the advertising experience into a one-stop shop and allows monetization of specialized data sets across several verticals. A recent article discussing this quotes SRAX CEO and founder Christopher Miglino, who says, “’Our primary focus is figuring out ways to monetize different data sets. We had a business a few years ago where we aggregated data on doctors in the country, and then we…

Continue Reading